奥曲肽在肝转移瘤姑息治疗中的应用：对临床病情稳定是否有效？ - Suppr

Suppr

超能文献

Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?

作者信息

Pistevou-Gompaki Kiki, Eleftheriadis Nikos, Eleftheriadis Damianos, Papaloukas Christos, Hatzitolios Apostolos

机构信息

Department of Radiation Oncology, Aristotle's University of Thessaloniki, Greece.

出版信息

Clin Med Oncol. 2008;2:401-3. doi: 10.4137/cmo.s409. Epub 2008 May 13.

DOI:10.4137/cmo.s409

PMID:21892306

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3161653/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2759/3161653/895dd5b87766/cmo-2-2008-401f1.jpg

相似文献

Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?奥曲肽在肝转移瘤姑息治疗中的应用：对临床病情稳定是否有效？

Clin Med Oncol. 2008;2:401-3. doi: 10.4137/cmo.s409. Epub 2008 May 13.

Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire.

Palliat Med. 2003 Apr;17(3):257-62. doi: 10.1191/0269216303pm698oa.

Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.肝减瘤术联合一种新型长效生长抑素类似物：治疗转移至肝脏的难治性神经内分泌肿瘤的范例

Surgery. 2001 Dec;130(6):954-62. doi: 10.1067/msy.2001.118388.

Octreotide in Palliative Treatment of Unresectable Cholangiocarcinoma: Is it Effective for Disease Stabilization?奥曲肽在不可切除胆管癌姑息治疗中的应用：对疾病稳定有效吗？

Clin Med Oncol. 2008;2:367-9. doi: 10.4137/cmo.s677. Epub 2008 Apr 24.

[Multimodal therapy improved carcinoid syndrome secondary to liver metastases of an atypical lung carcinoid tumor:a case report].

Nihon Shokakibyo Gakkai Zasshi. 2020;117(7):635-645. doi: 10.11405/nisshoshi.117.635.

Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge.进入使用长效奥曲肽治疗神经内分泌肿瘤的第三个十年经验：当前知识综述

Tumori. 2019 Apr;105(2):113-120. doi: 10.1177/0300891618765362. Epub 2018 Apr 6.

[Safety and efficacy of transarterial embolization combined with octreotide LAR on reducing tumor burden for neuroendocrine tumor liver metastasis].经动脉栓塞联合长效奥曲肽对减轻神经内分泌肿瘤肝转移瘤负荷的安全性和有效性

Zhonghua Yi Xue Za Zhi. 2019 Apr 16;99(15):1142-1146. doi: 10.3760/cma.j.issn.0376-2491.2019.15.005.

Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.长效奥曲肽用于晚期卵巢癌肠梗阻的治疗及症状缓解

J Pain Symptom Manage. 2005 Dec;30(6):563-9. doi: 10.1016/j.jpainsymman.2005.05.018.

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.奥曲肽长效注射剂（LAR）对转移性中肠神经内分泌肿瘤患者肿瘤生长控制效果的安慰剂对照、双盲、前瞻性、随机研究：PROMID研究组报告

J Clin Oncol. 2009 Oct 1;27(28):4656-63. doi: 10.1200/JCO.2009.22.8510. Epub 2009 Aug 24.

Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours.奥曲肽长效释放制剂作为晚期神经内分泌肿瘤一线治疗的抗增殖活性预测因素

Br J Cancer. 2016 Nov 22;115(11):1321-1327. doi: 10.1038/bjc.2016.349. Epub 2016 Nov 3.

本文引用的文献

Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire.

Palliat Med. 2003 Apr;17(3):257-62. doi: 10.1191/0269216303pm698oa.

Is octreotide useful for hepatic metastases due to non-neuroendocrine primary tumors?奥曲肽对非神经内分泌原发性肿瘤所致肝转移是否有效？

Clin Oncol (R Coll Radiol). 2002 Aug;14(4):330-1. doi: 10.1053/clon.2002.0084.

Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.奥曲肽与5-氟尿嘧啶或5-氟尿嘧啶加亚叶酸钙化疗方案用于晚期外分泌性胰腺癌的Ⅲ期评估：一项北中部癌症治疗组的研究

Clin Cancer Res. 2000 Sep;6(9):3486-92.

Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors.长效缓释兰瑞肽治疗晚期神经内分泌肿瘤患者

Am J Clin Oncol. 2000 Aug;23(4):412-5. doi: 10.1097/00000421-200008000-00020.

Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo.长效生长抑素类似物兰瑞肽在体外和体内对肝细胞癌的治疗作用

Int J Oncol. 2000 Jun;16(6):1197-201. doi: 10.3892/ijo.16.6.1197.

Somatostatin and hepatocellular carcinoma.生长抑素与肝细胞癌

Gastroenterology. 1998 Nov;115(5):1298-9. doi: 10.1016/s0016-5085(98)70109-x.

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.用奥曲肽治疗肝细胞癌：一项随机对照研究。

Gut. 1998 Mar;42(3):442-7. doi: 10.1136/gut.42.3.442.

High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects.高剂量兰瑞肽治疗晚期胃肠神经内分泌肿瘤患者：临床及生物学效应

Ann Oncol. 1997 Oct;8(10):1041-4. doi: 10.1023/a:1008205415035.

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment Group and the Mayo Clinic.生长抑素类似物（奥曲肽）治疗无症状晚期结肠癌患者的III期评估。中北部癌症治疗组和梅奥诊所。

Cancer. 1995 Sep 15;76(6):961-6. doi: 10.1002/1097-0142(19950915)76:6<961::aid-cncr2820760608>3.0.co;2-a.

Somatostatin analog induces insulin-like growth factor binding protein-1 (IGFBP-1) expression in human hepatoma cells.生长抑素类似物诱导人肝癌细胞中胰岛素样生长因子结合蛋白-1（IGFBP-1）的表达。

Endocrinology. 1992 Nov;131(5):2479-81. doi: 10.1210/endo.131.5.1385103.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验